PURPOSE OF REVIEW: Patients with rheumatoid arthritis (RA) have accelerated atherosclerosis despite the appearance of having a less atherogenic lipid profile; however, lipoprotein function rather than concentration may be a better indicator of atherosclerotic risk. The purpose of this review is to summarize recent findings concerning HDL function in patients with RA. RECENT FINDINGS: Two major activities of HDL, its antioxidant and cholesterol efflux functions have been examined in RA. HDL antioxidant capacity is inversely associated with inflammation and RA disease activity; however, there is no clear consensus if antioxidant capacity is altered significantly in RA compared with control study participants. Moreover, despite numerous studies there is no consensus whether HDL cholesterol efflux capacity is significantly altered in RA compared with control study participants or influenced by inflammation or disease activity. SUMMARY: Additional studies will be valuable to consolidate existing data and find consensus. Moreover, studies evaluating the impact of various HDL functions on cardiovascular disease in RA are needed.
PURPOSE OF REVIEW: Patients with rheumatoid arthritis (RA) have accelerated atherosclerosis despite the appearance of having a less atherogenic lipid profile; however, lipoprotein function rather than concentration may be a better indicator of atherosclerotic risk. The purpose of this review is to summarize recent findings concerning HDL function in patients with RA. RECENT FINDINGS: Two major activities of HDL, its antioxidant and cholesterol efflux functions have been examined in RA. HDL antioxidant capacity is inversely associated with inflammation and RA disease activity; however, there is no clear consensus if antioxidant capacity is altered significantly in RA compared with control study participants. Moreover, despite numerous studies there is no consensus whether HDL cholesterol efflux capacity is significantly altered in RA compared with control study participants or influenced by inflammation or disease activity. SUMMARY: Additional studies will be valuable to consolidate existing data and find consensus. Moreover, studies evaluating the impact of various HDL functions on cardiovascular disease in RA are needed.
Authors: Theodoros Kelesidis; Judith S Currier; Diana Huynh; David Meriwether; Christina Charles-Schoeman; Srinivasa T Reddy; Alan M Fogelman; Mohamad Navab; Otto O Yang Journal: J Lipid Res Date: 2011-09-27 Impact factor: 5.922
Authors: Young Hee Rho; Cecilia P Chung; Annette Oeser; Joseph F Solus; Tebeb Gebretsadik; Ayumi Shintani; Paolo Raggi; Ginger L Milne; C Michael Stein Journal: Arthritis Care Res (Hoboken) Date: 2010-10 Impact factor: 4.794
Authors: Cecilia P Chung; Annette Oeser; Paolo Raggi; Tebeb Gebretsadik; Ayumi K Shintani; Tuulikki Sokka; Theodore Pincus; Ingrid Avalos; C Michael Stein Journal: Arthritis Rheum Date: 2005-10
Authors: Christina Charles-Schoeman; Yuen Yin Lee; Victor Grijalva; Sogol Amjadi; John FitzGerald; Veena K Ranganath; Mihaela Taylor; Maureen McMahon; Harold E Paulus; Srinivasa T Reddy Journal: Ann Rheum Dis Date: 2012-01-20 Impact factor: 19.103
Authors: Elena Myasoedova; Cynthia S Crowson; Hilal Maradit Kremers; Veronique L Roger; Patrick D Fitz-Gibbon; Terry M Therneau; Sherine E Gabriel Journal: Ann Rheum Dis Date: 2011-01-07 Impact factor: 19.103
Authors: Maureen McMahon; Jennifer Grossman; John FitzGerald; Erika Dahlin-Lee; Daniel J Wallace; Bernard Y Thong; Humeira Badsha; Kenneth Kalunian; Christina Charles; Mohamad Navab; Alan M Fogelman; Bevra H Hahn Journal: Arthritis Rheum Date: 2006-08
Authors: Anuradha Vivekanandan-Giri; Jessica L Slocum; Jaeman Byun; Chongren Tang; Robin L Sands; Brenda W Gillespie; Jay W Heinecke; Rajiv Saran; Mariana J Kaplan; Subramaniam Pennathur Journal: Ann Rheum Dis Date: 2013-01-12 Impact factor: 19.103
Authors: Katherine P Liao; Tianxi Cai; Vivian S Gainer; Andrew Cagan; Shawn N Murphy; Chihchin Liu; Susanne Churchill; Stanley Y Shaw; Isaac Kohane; Daniel H Solomon; Robert M Plenge; Elizabeth W Karlson Journal: Arthritis Care Res (Hoboken) Date: 2013-12 Impact factor: 4.794
Authors: Christina Charles-Schoeman; Junji Watanabe; Yuen Yin Lee; Daniel E Furst; Sogol Amjadi; David Elashoff; Grace Park; Maureen McMahon; Harold E Paulus; Alan M Fogelman; Srinivasa T Reddy Journal: Arthritis Rheum Date: 2009-10
Authors: Kevin W Byram; Annette M Oeser; MacRae F Linton; Sergio Fazio; C Michael Stein; Michelle J Ormseth Journal: J Clin Rheumatol Date: 2018-12 Impact factor: 3.517
Authors: Michelle J Ormseth; Patricia G Yancey; Joseph F Solus; S Louis Bridges; Jeffrey R Curtis; MacRae F Linton; Sergio Fazio; Sean S Davies; L Jackson Roberts; Kasey C Vickers; Valentina Kon; C Michael Stein Journal: Arthritis Rheumatol Date: 2016-09 Impact factor: 10.995
Authors: Mansoor Karimifar; Mohammad S Sepehrifar; Hamidreza Moussavi; Mohammad B Sepehrifar; Peyman Mottaghi; Mansour Siavash; Mozhgan Karimifar Journal: J Res Med Sci Date: 2018-12-28 Impact factor: 1.852
Authors: João F S Rodrigues; Liziane C M da Silva; Leia Cardoso-Sousa; Douglas Carvalho Caixeta; Debora D Lückemeyer; Alisson S Henrique; Jaqueline P Pontes; Lycia M G da Silva; Juliana S S Macedo; Pedro S Carvalho Júnior; Cristiane Silva E Silva; Mahiba M R S Martins; Valério Monteiro-Neto; Marcos A G Grisotto; Anita M R Fernandes; Juliano Ferreira; João B Calixto; Robinson Sabino-Silva; Elizabeth S Fernandes Journal: Pharmaceuticals (Basel) Date: 2021-01-29